Latest Insider Transactions at Intellia Therapeutics, Inc. (NTLA)
This section provides a real-time view of insider transactions for Intellia Therapeutics, Inc. (NTLA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Intellia Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Intellia Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2021
|
Jose E Rivera EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
97,001
+13.04%
|
$1,261,013
$13.4 P/Share
|
|
Apr 01
2021
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
38,209
-2.71%
|
$3,171,347
$83.5 P/Share
|
|
Apr 01
2021
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
71,041
+4.77%
|
$923,533
$13.99 P/Share
|
|
Feb 26
2021
|
Jean Francois Formela Director |
SELL
Open market or private sale
|
Indirect |
501,945
-31.07%
|
$30,116,700
$60.29 P/Share
|
|
Feb 09
2021
|
Jose E Rivera EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
11,489
-8.88%
|
$861,675
$75.0 P/Share
|
|
Feb 09
2021
|
Jose E Rivera EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
21,000
+13.96%
|
$378,000
$18.3 P/Share
|
|
Feb 09
2021
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
28,043
-4.07%
|
$2,103,225
$75.0 P/Share
|
|
Feb 09
2021
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
56,718
+7.61%
|
$340,308
$6.83 P/Share
|
|
Feb 05
2021
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
22,942
-1.18%
|
$1,537,114
$67.94 P/Share
|
|
Feb 05
2021
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+5.76%
|
$520,000
$13.4 P/Share
|
|
Feb 03
2021
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
67,856
-5.35%
|
$4,885,632
$72.5 P/Share
|
|
Feb 03
2021
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
117,060
+8.42%
|
$2,107,080
$18.33 P/Share
|
|
Feb 01
2021
|
Jose E Rivera EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
54,659
-5.43%
|
$3,498,176
$64.19 P/Share
|
|
Feb 01
2021
|
Jose E Rivera EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
109,000
+21.63%
|
$1,199,000
$11.76 P/Share
|
|
Feb 01
2021
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
109,889
-1.62%
|
$7,032,896
$64.14 P/Share
|
|
Feb 01
2021
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+7.71%
|
$3,000,000
$15.45 P/Share
|
|
Jan 20
2021
|
Fred E Cohen |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+40.0%
|
$260,000
$13.78 P/Share
|
|
Jan 05
2021
|
Jose E Rivera EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
2,078
-3.84%
|
$114,290
$55.86 P/Share
|
|
Jan 05
2021
|
Andrew Schiermeier EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,377
-7.64%
|
$75,735
$55.86 P/Share
|
|
Jan 05
2021
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
6,239
-1.3%
|
$343,145
$55.86 P/Share
|
|
Dec 31
2020
|
Jose E Rivera EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,792
+8.14%
|
-
|
|
Dec 31
2020
|
Andrew Schiermeier EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,792
+20.99%
|
-
|
|
Dec 31
2020
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,375
+2.9%
|
-
|
|
Dec 30
2020
|
Andrew Schiermeier EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+10.58%
|
$19,500
$13.48 P/Share
|
|
Dec 17
2020
|
Perry A Karsen Director |
SELL
Open market or private sale
|
Direct |
88,764
-55.92%
|
$4,704,492
$53.51 P/Share
|
|
Dec 17
2020
|
Perry A Karsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
88,764
+27.22%
|
$1,597,752
$18.53 P/Share
|
|
Dec 01
2020
|
Jose E Rivera EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
3,364
-2.19%
|
$127,832
$38.56 P/Share
|
|
Dec 01
2020
|
Jose E Rivera EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.76%
|
$65,000
$13.88 P/Share
|
|
Nov 27
2020
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
35,000
-3.61%
|
$1,330,000
$38.5 P/Share
|
|
Nov 27
2020
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+3.48%
|
$560,000
$16.44 P/Share
|
|
Nov 25
2020
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-9.66%
|
$1,800,000
$36.0 P/Share
|
|
Nov 25
2020
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+8.81%
|
$300,000
$6.83 P/Share
|
|
Nov 18
2020
|
Jose E Rivera EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
624
-1.31%
|
$21,840
$35.0 P/Share
|
|
Nov 18
2020
|
Jose E Rivera EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
848
+1.75%
|
$15,264
$18.3 P/Share
|
|
Nov 16
2020
|
Jose E Rivera EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
6,029
-3.96%
|
$204,986
$34.42 P/Share
|
|
Nov 16
2020
|
Jose E Rivera EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,562
+8.61%
|
$126,744
$12.57 P/Share
|
|
Nov 16
2020
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-4.1%
|
$680,000
$34.0 P/Share
|
|
Nov 16
2020
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.94%
|
$280,000
$14.58 P/Share
|
|
Nov 04
2020
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-9.66%
|
$1,300,000
$26.0 P/Share
|
|
Nov 04
2020
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+8.81%
|
$300,000
$6.83 P/Share
|
|
Nov 04
2020
|
Jose E Rivera EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
3,364
-7.36%
|
$94,192
$28.0 P/Share
|
|
Nov 04
2020
|
Jose E Rivera EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.87%
|
$65,000
$13.88 P/Share
|
|
Oct 15
2020
|
Jose E Rivera EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
5,615
-6.09%
|
$134,760
$24.37 P/Share
|
|
Oct 15
2020
|
Jose E Rivera EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.76%
|
$60,000
$6.83 P/Share
|
|
Oct 07
2020
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.06%
|
$105,000
$21.83 P/Share
|
|
Oct 07
2020
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.05%
|
$30,000
$6.83 P/Share
|
|
Dec 12
2017
|
Novartis Institutes For Bio Medical Research, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,523,000
-26.94%
|
$27,414,000
$18.3 P/Share
|
|
Mar 03
2017
|
Novartis Institutes For Bio Medical Research, Inc. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
79,245
+1.38%
|
-
|
|
May 11
2016
|
Novartis Institutes For Bio Medical Research, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
277,777
+4.75%
|
$4,999,986
$18.0 P/Share
|
|
May 11
2016
|
Novartis Institutes For Bio Medical Research, Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
5,295,881
+28.31%
|
-
|